Si (gp) L.p. Crestline, 10% Owner at Juno Therapeutics, Inc. (JUNO), bought 9,375,000 shares at $25.00 ($15.6M) on 2014-12-19, disclosed to the SEC on 2014-12-23.
Open-market purchase of $15.6M JUNO by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.00 | 625,000 | $15.6M | 100.0% |
| 2 | $0.00 | 8,750,000 | $0 | 0.0% |
| Total | $1.67 avg | 9,375,000 | $15.6M | 100% |